REL proto-oncogene (c-Rel) (C-Term) Peptide
c-Rel
适用: 人, 小鼠
宿主: 合成
BP, WB
-
- 抗原 See all c-Rel products
- c-Rel (REL proto-oncogene (c-Rel))
- 蛋白结构域
- C-Term
- 宿主
- 人, 小鼠
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 序列
- FSCVDNGLMN EPGLSDDANN PTFVQSSHYS VNTLQSEQLS DPFTYGFFKI
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-Rel Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeat freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- c-Rel (REL proto-oncogene (c-Rel))
- 别名
- C-Rel Peptide, c-Rel Peptide, NFkB Peptide, c-rel Peptide, zgc:100833 Peptide, Xrel2 Peptide, Xrel3 Peptide, rel Peptide, rel-A Peptide, rel2 Peptide, rel3 Peptide, v-rel Peptide, xrel Peptide, REL proto-oncogene, NF-kB subunit Peptide, reticuloendotheliosis oncogene Peptide, RELA proto-oncogene, NF-kB subunit Peptide, v-rel avian reticuloendotheliosis viral oncogene homolog Peptide, v-rel avian reticuloendotheliosis viral oncogene homolog L homeolog Peptide, ribonuclease A family member 2 pseudogene Peptide, REL Peptide, Rel Peptide, Rela Peptide, rel Peptide, rel.L Peptide, ECRP Peptide
- 背景
-
Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The NF-kappa-B heterodimer RELA/p65-c-Rel is a transcriptional activator.
Protein Size: 587 - 分子量
- 64 kDa
- UniProt
- P15307
-
You are here:
